Search

Financial Highlights

  In Rupiah billion In SGD million*
  2020
Actual
(Restated**)
2021
Actual
(Restated**)
2022 Actual 2020
Actual
(Restated**)
2021
Actual
(Restated**)
2022 Actual
Revenue 14,475 19,659 17,797 1,344 1,826 1,653
Gross profit 2,919 5,073 4,559 271 471 423
Gain/(loss) arising from changes in fair value of biological assets 3 113 (136) 0.3 10 (13)
Profit from operations 1,479 2,826 2,702 137 263 251
Net profit after tax 164 1,287 1,318 15 119 122
Profit attributable to owners of the Company 20 759 770 2 71 72
EPS (in Rp)/(in SGD ‘cents) 14 544 552 0.1 5.1 5.2
Current assets 7,808 9,550 10,552 670 819 905
Fixed assets 19,374 18,527 18,136 1,662 1,589 1,556
Other non-current assets 10,292 9,559 9,578 883 820 822
Total assets 37,474 37,636 38,266 3,214 3,228 3,282
Current liabilities 9,204 9,970 9,883 789 855 848
Non-current liabilities 7,755 6,230 5,231 665 534 449
Total liabilities 16,959 16,200 15,114 1,455 1,389 1,296
Shareholders' equity 11,353 11,601 12,900 974 995 1,106
Total equity 20,515 21,436 23,152 1,760 1,839 1,986
Total debt 11,356 10,334 9,144 974 886 784
Cash 2,446 3,764 4,422 210 323 379
 
In Percentage (%)
Sales growth/(decline) 6.0% 35.8% (9.5%)  
Gross profit margin 20.2% 25.8% 25.6%
Profit from operations margin 10.2% 14.4% 15.2%
Net profit after tax margin 1.1% 6.5% 7.4%
Profit attributable to owners of the
Company margin
0.1% 3.9% 4.3%
Return on assets1 3.9% 7.5% 7.1%
Return on equity2 0.2% 6.5% 6.0%
Current ratio (times) 0.8 1.0 1.1
Net debt to equity ratio (times)3 0.43 0.31 0.20
Total debt to total assets ratio (times) 0.30 0.27 0.24

1 Profit from operations divided by total assets
2 Profit attributable to owners of the Company divided by shareholders’ equity
3 Net debt divided by total equity

* For ease of reference, 2020 to 2022 Income Statement and Balance Sheet items are converted at exchange rates of 10,767/SGD1 and Rp11,659/SGD1, respectively.
** The restated figures were related to the application of IFRIC Agenda Decision on SFRS(I) 1-19 Employee Benefits.

Investor Relations